Pharmatech Associates Helps Intelliject Prepare for Pre-Approval Inspections Leading to Tentative Approval of its New Drug Application for e-cue  
10/19/2011 10:45:39 AM

HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates, a compliance consulting firm serving companies in the pharmaceutical, biotech and medical device industries, was instrumental in helping Intelliject and it’s manufacturing suppliers prepare for and pass all of the FDA pre-approval inspections associated with its New Drug Application for an innovative epinephrine auto-injector, e-cue™.